Alan Prem Kumar
- Toxicology top 0.02%
- Bioactive Compounds and Antitumor Agents 19
- Cancer Research top 0.2%
- Cancer-related molecular mechanisms research 25
- MicroRNA in disease regulation 20
- Complementary and alternative medicine top 0.05%
- Molecular Medicine top 0.5%
- Molecular Biology top 0.2%
- Natural product bioactivities and synthesis 22
- PI3K/AKT/mTOR signaling in cancer 14
- Circular RNAs in diseases 14
-
- Cytokine Signaling Pathways and Interactions 29
-
- Cancer Mechanisms and Therapy 20
Alan Prem Kumar
247 papers receiving 19.1k citations
Hit Papers
Peers
Comparison fields: 5 of 171
- Toxicology 1.5k
- Cancer Research 4.2k
- Complementary and alternative medicine 1.7k
- Molecular Medicine 922
- Molecular Biology 11.2k
Countries citing papers authored by Alan Prem Kumar
This map shows the geographic impact of Alan Prem Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Prem Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Prem Kumar more than expected).
Fields of papers citing papers by Alan Prem Kumar
This network shows the impact of papers produced by Alan Prem Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Prem Kumar. The network helps show where Alan Prem Kumar may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alan Prem Kumar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 12 | |
| 5 | 2023 | 14 | |
| 6 | 2023 | 3 | |
| 7 | 2021 | 12 | |
| 8 | 2021 | 65 | |
| 9 | 2021 | 90 | |
| 10 | 2020 | 99 | |
| 11 | 2020 | 97 | |
| 12 | 2020 | 63 | |
| 13 | 2020 | 72 | |
| 14 | 2019 | 23 | |
| 15 | 2019 | 259 | |
| 16 | 2019 | 69 | |
| 17 | 2018 | 2 | |
| 18 | The Role of Resveratrol in Cancer Therapybreakdown → | 2017 | 603 |
| 19 | 2016 | 82 | |
| 20 | 2009 | 57 |
About Alan Prem Kumar
Alan Prem Kumar is a scholar working on Toxicology, Cancer Research and Molecular Biology, having authored 251 papers that have together received 19.3k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (29 papers), Cancer-related molecular mechanisms research (25 papers), Natural product bioactivities and synthesis (22 papers), MicroRNA in disease regulation (20 papers), Cancer Mechanisms and Therapy (20 papers), Bioactive Compounds and Antitumor Agents (19 papers), PI3K/AKT/mTOR signaling in cancer (14 papers) and Circular RNAs in diseases (14 papers). The work is most often cited by research in Toxicology (1.5k citations), Cancer Research (4.2k citations) and Complementary and alternative medicine (1.7k citations). Alan Prem Kumar has collaborated with scholars based in Singapore, Australia and United States. Frequent co-authors include Gautam Sethi, Muthu K. Shanmugam, Frank Arfuso, Kwang Seok Ahn, Anupam Bishayee, Xiaoyun Dai, Benny K.H. Tan, Kam M. Hui, Kodappully Sivaraman Siveen and Milad Ashrafizadeh. Their work appears in journals such as International Journal of Molecular Sciences, Biomolecules, Cancer Letters, Cancers and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.